NASDAQ:AUPH

Aurinia Pharmaceuticals Stock News

etoro logo Buy AUPH
*Your capital is at risk
$16.37
+0.700 (+4.47%)
At Close: Jun 04, 2026
H.C. Wainwright analyst Ed Arce maintained a Buy rating on Albireo Pharma ( ALBO – Research Report ) today and set a price target of $62.00 . The company’s shares closed last Monday at $24.22. Acc
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Navidea (NAVB), GlycoMimetics (GLYC) and Akero Therapeutics
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Navidea ( NAVB – Research Report ), GlycoMimetics ( GLYC – Research Report ) and Akero Therapeutics
Clinical trials have historically hewn to a rigid format. A trial is designed, conducted according to that design, and then results are analyzed. Making
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Gilead Sciences (GILD

Healthcare Faces A Contagion

02:36pm, Thursday, 27'th Feb 2020
Fear mounts as investors brace for a viral outbreak in the US. Volatility to remain high as Covid-19 virus remains an unknown threat. Impact on earnings outlook
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Novavax (NVAX), Madrigal Pharmaceuticals (MDGL) and CareDx
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Novavax ( NVAX – Research Report ), Madrigal Pharmaceuticals ( MDGL – Research Report ) and CareDx
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Agios Pharma (AGIO), Fate Therapeutics (FATE) and
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Agios Pharma

3 Canadian Biotechs to Consider Buying Today

12:00pm, Friday, 07'th Feb 2020
These developers of drugs for cancer, neurological conditions, and rare diseases may boost risk-taking investors' portfolios.
Research Analysts’ upgrades for Friday, February 7th: Alnylam Pharmaceuticals (NASDAQ:ALNY) was upgraded by analysts at BidaskClub from a buy rating to a strong-buy rating. Applied Materials (NASDAQ
Finding a stock which will deliver enormous returns is the Street’s holy grail. Upon first glance, this task may seem rather simple. Step 1 is to pinpoint a company with a small market cap and low v
Finding a stock which will deliver enormous returns is the Street’s holy grail. Upon first glance, this task may seem rather simple. Step 1 is to pinpoint
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE